289 related articles for article (PubMed ID: 16514788)
1. Singer's dystonia: first report of a variant of spasmodic dysphonia.
Chitkara A; Meyer T; Keidar A; Blitzer A
Ann Otol Rhinol Laryngol; 2006 Feb; 115(2):89-92. PubMed ID: 16514788
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic and therapeutic difficulties in laryngeal dystonia].
Niebudek-Bogusz E; Modzelewska-Radwan B; Pietruszewska W; Zielińska M; Gryczyński M
Otolaryngol Pol; 2003; 57(5):739-45. PubMed ID: 14994622
[TBL] [Abstract][Full Text] [Related]
3. Task-specific singing dystonia: vocal instability that technique cannot fix.
Halstead LA; McBroom DM; Bonilha HS
J Voice; 2015 Jan; 29(1):71-8. PubMed ID: 25008376
[TBL] [Abstract][Full Text] [Related]
4. Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): a 12-year experience in more than 900 patients.
Blitzer A; Brin MF; Stewart CF
Laryngoscope; 1998 Oct; 108(10):1435-41. PubMed ID: 9778279
[TBL] [Abstract][Full Text] [Related]
5. [Indications for botulinum toxin in laryngectomy].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E; Cohen M
Rev Laryngol Otol Rhinol (Bord); 1993; 114(4):281-7. PubMed ID: 8029549
[TBL] [Abstract][Full Text] [Related]
6. Laryngeal dystonia: case report and treatment with botulinum toxin.
Santos VJ; Mattioli FM; Mattioli WM; Daniel RJ; Cruz VP
Braz J Otorhinolaryngol; 2006; 72(3):425-7. PubMed ID: 17119783
[TBL] [Abstract][Full Text] [Related]
7. Botulinum toxin management of adductor spasmodic dysphonia after failed recurrent laryngeal nerve section.
Sulica L; Blitzer A; Brin MF; Stewart CF
Ann Otol Rhinol Laryngol; 2003 Jun; 112(6):499-505. PubMed ID: 12834116
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum toxin. A new therapeutic alternative in spastic dysphonia (laryngeal abductor dystonia)].
Loven JO; Brøndbo K; Ganes T
Tidsskr Nor Laegeforen; 1993 Mar; 113(7):841-3. PubMed ID: 8480289
[TBL] [Abstract][Full Text] [Related]
9. Spasmodic Dysphonia.
Lin J; Sadoughi B
Adv Otorhinolaryngol; 2020; 85():133-143. PubMed ID: 33166970
[TBL] [Abstract][Full Text] [Related]
10. Longitudinal effects of botulinum toxin injections on voice-related quality of life (V-RQOL) for patients with adductory spasmodic dysphonia.
Hogikyan ND; Wodchis WP; Spak C; Kileny PR
J Voice; 2001 Dec; 15(4):576-86. PubMed ID: 11792036
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in onabotulinum toxin A dosing for adductor spasmodic dysphonia.
Lerner MZ; Lerner BA; Patel AA; Blitzer A
Laryngoscope; 2017 May; 127(5):1131-1134. PubMed ID: 27633917
[TBL] [Abstract][Full Text] [Related]
12. Combined modality treatment of adductor spasmodic dysphonia.
Silverman EP; Garvan C; Shrivastav R; Sapienza CM
J Voice; 2012 Jan; 26(1):77-86. PubMed ID: 21292439
[TBL] [Abstract][Full Text] [Related]
13. Outcomes assessment following treatment of spasmodic dysphonia with botulinum toxin.
Courey MS; Garrett CG; Billante CR; Stone RE; Portell MD; Smith TL; Netterville JL
Ann Otol Rhinol Laryngol; 2000 Sep; 109(9):819-22. PubMed ID: 11007083
[TBL] [Abstract][Full Text] [Related]
14. Considerations for initial dosing of botulinum toxin in treatment of adductor spasmodic dysphonia.
Rosow DE; Parikh P; Vivero RJ; Casiano RR; Lundy DS
Otolaryngol Head Neck Surg; 2013 Jun; 148(6):1003-6. PubMed ID: 23535709
[TBL] [Abstract][Full Text] [Related]
15. [Treatment of spasmodic dysphonia with botulinum toxin].
Klap P; Marion MH; Perrin A; Fresnel-Elbaz E
Ann Otolaryngol Chir Cervicofac; 1991; 108(8):477-82; discussion 482-3. PubMed ID: 1789624
[TBL] [Abstract][Full Text] [Related]
16. Adductor muscle activity abnormalities in abductor spasmodic dysphonia.
Cyrus CB; Bielamowicz S; Evans FJ; Ludlow CL
Otolaryngol Head Neck Surg; 2001 Jan; 124(1):23-30. PubMed ID: 11228447
[TBL] [Abstract][Full Text] [Related]
17. Listening: the key to diagnosing spasmodic dysphonia.
Braden MN; Hapner ER
ORL Head Neck Nurs; 2008; 26(1):8-12. PubMed ID: 18274236
[TBL] [Abstract][Full Text] [Related]
18. Botulinum toxin treatment of false vocal folds in adductor spasmodic dysphonia: Functional outcomes.
Simpson CB; Lee CT; Hatcher JL; Michalek J
Laryngoscope; 2016 Jan; 126(1):118-21. PubMed ID: 26467807
[TBL] [Abstract][Full Text] [Related]
19. Identification of symptoms for spasmodic dysphonia and vocal tremor: a comparison of expert and nonexpert judges.
Barkmeier JM; Case JL; Ludlow CL
J Commun Disord; 2001; 34(1-2):21-37. PubMed ID: 11322567
[TBL] [Abstract][Full Text] [Related]
20. Surgery or botulinum toxin for adductor spasmodic dysphonia: a comparative study.
Mendelsohn AH; Berke GS
Ann Otol Rhinol Laryngol; 2012 Apr; 121(4):231-8. PubMed ID: 22606926
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]